Hypertension in the lungs is a relatively rare but very serious disease that is usually fatal within two years if left untreated. Current therapies can slow down its progression, but no cure exists. Research teams from Bochum and Bonn are shedding light on the underlying mechanisms of the disease, and have discovered a previously unrecognized factor in its development: the protein beta arrestin 1. The teams have shown that this protein plays an important role in transporting signaling molecules involved in regulating blood vessel diameter. The researchers report their findings in the Proceedings of the National Academy of Sciences.
This article was originally published on MedicalXpress.com
